Sitemap
- Market Surveillance
- For Consumers
- Facts worth knowing about medicines
- Clinical Trials
- Medicines from the Internet
- Illegal market
- Medical devices
- For Healthcare Professionals
- Safety information (DHPC)
- Clinical trials
- Blood safety
- Tissue safety
- Medical Devices Operator
- Bringing into circulation
- Austrian Pharmacopoeia
- CHMP Meeting Highlights-BASG
- For Companies
- Online services
- Marketing authorisation & life-cycle
- Marketing authorisation procedure
- Central Authorisation
- MRP/DCP authorisation
- National Authorisation
- Registration in IRIS
- Line Extension
- Utilisation of genetic resources and traditional knowledge associated with genetic resources
- Parallel import
- Accessible patient information leaflet
- Safety features AMVS
- Classification and supply of substances under control
- Austria as RMS
- Electronic application
- AGES eValidator
- FAQ electronic Submission
- Life-Cycle
- Commission decisions
- Forms for medicinal products
- Change of ownership acc. to Art 25 AMG (human) or Art 16 TAMG (veterinary)
- Veterinary medicinal products
- Austria as RMS
- The EU veterinary medicinal products (VMP) regulation
- European guidelines
- Application for Marketing Authorisation and Variations
- Implementation of new QRD templates
- Application acc. to Article 13 of Regulation (EU) 2019/6
- SPC harmonisation
- Clinical trials
- Pharmacovigilance
- Union Product Database (UPD)
- Notification of pet products
- Herd-specific/Autologous vaccines
- National Legislation / Information
- Antimicrobial Consumption
- Contact
- FAQ marketing authorisation & life-cycle
- Application for variation
- BREXIT
- Art. 5(3) referral on nitrosamines in human medicinal products
- Austrian Medicinal Product Index
- ATC/DDD Index 2025
- ASMF
- Decisions - electronic delivery
- Braille writing system
- Batch release
- CEP
- Anti-doping warning
- Elemental Impurities - ICHQ3D
- Environmental Risk Assessment (ERA)
- SmPC and PL
- Accessible patient information leaflet
- Homeopathic Medicinal Products
- Annual fee
- Medicines for children/Paediatric Worksharing
- Mock-ups
- Naming of medicinal products
- Parallelimport
- Herbal Medicinal Products
- Black Triangle
- Sunset clause
- Renewal of marketing authorisation
- Distributor in Austria
- Authorisation/registration applications
- Drug-Device Combinations
- Marketing authorisation procedure
- Pharmacovigilance
- Medicinal products
- Import and export of medicines
- Medical devices
- Authorisation and certification
- Borderline products
Page last modified:
15/09/2022